About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
IRWD - Ironwood Pharmaceuti...| Previous Close | $11.33 | Open | $11.30 |
| Volume | 1.73M | Market Cap | 1.709B |
| Yield | Last Dividend |
| Ironwood Pharmaceuticals to Present at t... | 01/05/21 |
| Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, will provide a corporate overview during a presentation and Q&A se | |
| Ironwood Pharmaceuticals to Present at t... | 11/06/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in a virtual fireside chat at the 29th Annual Credit Suisse He... | |
| UPDATE 1-Ironwood appoints Sarissa's Den... | 11/06/20 |
| Ironwood Pharmaceuticals on Friday handed a board seat to Sarissa Capital Management, sparking its shares to surge as much as 14% when the activist in... | |
| Ironwood Pharmaceuticals Reports Strong ... | 11/05/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its third quarter... | |
| Ironwood Pharmaceuticals Appoints Alexan... | 11/05/20 |
| Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the appointment of Alexander Denner, Ph.D., to its Board of Directors, effective Novembe | |
| Ironwood Pharmaceuticals, Inc. to Host E... | 11/05/20 |
| NEW YORK, NY / ACCESSWIRE / November 5, 2020 / Ironwood Pharmaceuticals, Inc. | |
| Head to Head Analysis: Alexion Pharmaceu... | 10/24/20 |
| Alexion Pharmaceuticals (NASDAQ:ALXN) and Ironwood Pharmaceuticals (NASDAQ:IRWD) are both medical companies, but which is the superior stock? We will ... | |
| Ironwood Pharmaceuticals to Host Third Q... | 10/22/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2020 investor update conference ... | |
| Zacks: Brokerages Anticipate Ironwood Ph... | 10/20/20 |
| Equities research analysts expect Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to announce $0.14 earnings per share for the current quarter, Zacks Inv... | |
| Ironwood to Discontinue IW-3718 Developm... | 09/29/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that data from IW-3718-302, o... | |
| Ironwood Pharmaceuticals to Participate ... | 09/02/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences... | |
| Ironwood Pharmaceuticals Reports Second ... | 08/06/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its second quarte... | |
| Ironwood Pharmaceuticals to Host Second ... | 07/23/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2020 investor update conference... | |
| Hedge Funds Still Bullish On Ironwood Ph... | 06/06/20 |
| The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that sho... | |
| Why Is Ironwood (IRWD) Down 3.6% Since L... | 06/05/20 |
| Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Ironwood Pharmaceuticals (IRWD) Looks Go... | 06/03/20 |
| Ironwood Pharmaceuticals (IRWD) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes. | |
| Ironwood (IRWD) Misses Q1 Earnings and R... | 05/07/20 |
| Ironwood (IRWD) witnesses strong demand for Linzess in the first quarter. COVID-19 impacts enrollment in clinical studies. | |
| Ironwood Pharmaceuticals (IRWD) Misses Q... | 05/06/20 |
| Ironwood (IRWD) delivered earnings and revenue surprises of -63.64% and -7.90%, respectively, for the quarter ended March 2020. Do the numbers hold cl... | |
| Ironwood Pharmaceuticals Reports First Q... | 05/06/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its first quarter... | |
| Ironwood and Allergan Receive Notices of... | 04/28/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the United States Patent and Trademark Office (USPTO) has ... | |
| Ironwood Pharmaceuticals to Host First Q... | 04/16/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its first quarter 2020 investor update conference ... | |
| Can Ironwood (IRWD) Keep the Earnings Su... | 04/16/20 |
| Ironwood (IRWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat... | |
| Ironwood Pharmaceuticals Provides Update... | 03/26/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today provided an update on certain impacts o... | |
| Ironwood (IRWD) Down 22.1% Since Last Ea... | 03/14/20 |
| Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Ironwood (IRWD) Surpasses Q4 Earnings an... | 02/14/20 |
| Ironwood (IRWD) witnesses strong demand for Linzess in the fourth quarter as well. Stock up. | |
| Ironwood Pharmaceuticals Reports Strong ... | 02/13/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its fourth quarte... | |
| What's in Store for Ironwood (IRWD) This... | 02/10/20 |
| Ironwood Pharmaceuticals' (IRWD) Linzess is likely to have driven total revenues in the fourth quarter. | |
| Ironwood Pharmaceuticals (IRWD) Earnings... | 02/06/20 |
| Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... | |
| Ironwood Pharmaceuticals to Host Fourth ... | 01/30/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its fourth quarter and full- year 2019 investor up... | |
| Ironwood/Allergan settle patent dispute ... | 01/22/20 |
| Ironwood Pharmaceuticals (IRWD +0.8%) and licensee Allergan (AGN) have settled patent infringement litigation with Teva Pharmaceutical Industries (TEV... | |
| Hold rating | 11/06/20 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $11.00 to $12.00 | |
| Hold rating | 11/06/20 |
| Credit Suisse maintains Neutral rating and raises Price Target from $11.00 to $12.00 | |
| Date | 2020-11-05 (BMO) | Est. (EPS/Rev.) | $0.15/ 95.96M |
| Actual (EPS/Rev.) | $0.23/ $103.47 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
